Trial NCT02198482

View at ClinicalTrials.gov 
Org. Study IDs: AMLSG 20-13
Secondary IDs: 2014-000477-39

Last trial update was posted on 2018-02-28

MeSH Interventions

Cytarabine Daunorubicin Mitoxantrone

MeSH Conditions

Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute Myelodysplastic Syndromes Preleukemia Syndrome

Other Conditions

Acute Myeloid Leukemia (AML) High-risk Myelodysplastic Syndrome (MDS)

Stopping Reasons

development program of study drug volasertib was stopped by Boehringer Ingelheim due to manufacturing problems

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID